评估晚期卵巢癌患者的营养状态:哪种生物标志物最佳?
该研究回顾性纳入2003至2018年在梅奥诊所接受初次肿瘤细胞减灭术的627例卵巢癌患者,评估术前白蛋白、预后营养指数(PNI)、中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)对术后严重并发症和90天死亡的独立预测作用。结果显示四种标志物均与90天死亡相关,白蛋白预测价值最高;但均与严重并发症无关。
要点
- 白蛋白<3.5 g/dL、PNI<45、NLR>6和PLR≥200均与90天死亡单变量相关(均p<0.05)。
- 校正后白蛋白的OR最高为6.04(95%CI 2.80-13.03),AUC为0.83。
- PNI、NLR和PLR与严重并发症单变量相关,但校正后无显著关联。
核心结论
- 所有生物标志物在校正模型中均与90天死亡相关,其中白蛋白在临床上最易获得;均与严重并发症无关。
- 未来研究应减少对营养评估方法的关注,更多关注卵巢癌肿瘤导向治疗期间改善营养的策略。
研究设计与样本
- 回顾性研究,纳入2003至2018年在梅奥诊所接受手术的卵巢癌患者,共627例符合标准。
- 采用已建立的截断值,结局为严重并发症(Accordion分级≥3级)和90天死亡。
- 进行单变量和多变量逻辑回归分析,生物标志物分别在独立模型中评估。
主要发现
- 白蛋白<3.5 g/dL、PNI<45、NLR>6和PLR≥200在单变量中均与90天死亡相关(均p<0.05)。
- 校正年龄和ASA评分后,各标志物仍显著,白蛋白OR为6.04(95%CI 2.80-13.03),AUC为0.83。
- PNI<45、NLR>6和PLR≥200在单变量中与严重并发症相关(均p<0.05),但校正后未达显著。
- 白蛋白与严重并发症无关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advanced epithelial ovarian cancer (OC) patients often present with malnutrition; however, the ideal nutritional evaluation tool is unclear. We aimed to evaluate the role of preoperative albumin, Prognostic Nutritional Index [PNI], neutrophil-to-lymphocyte ratio [NLR], and platelet-to-lymphocyte ratio [PLR] as independent predictors of severe postoperative complications and 90-day mortality in OC patients who underwent primary cytoreductive surgery to identify the ideal tool. METHODS: OC patients who underwent surgery at Mayo Clinic (2003-2018) were included; biomarkers were retrospectively retrieved and established cut-offs were utilized. Outcomes included severe complications (Accordion grade ≥ 3) and 90-day mortality. Univariate and multivariable logistic regression models were performed. Biomarkers were evaluated in separate models adjusted for age and American Society of Anesthesiologists (ASA) score for 90-day mortality, and adjusted for age, ASA score, stage, and surgical complexity for severe complications. RESULTS: Albumin <3.5 g/dL, PNI < 45, NLR > 6 and PLR ≥ 200 were univariately associated with 90-day mortality (all p < 0.05) in 627 patients that met inclusion criteria. Each marker remained significant in adjusted models with albumin having the highest OR: 6.04 [95% CI:2.80-13.03] and AUC (0.83). Univariately, PNI <45, NLR >6, and PLR ≥200 were significant predictors of severe complications(all p < 0.05), however failed to reach significance in adjusted models. Albumin was not associated with severe complications. CONCLUSION: All biomarkers were associated with 90-day mortality in adjusted models, with albumin being the easiest predictor to attain clinically; none with severe complications. Future research should focus less on methods of nutritional assessment and more on strategies to improve nutrition during OC tumor-directed therapy.
引用
- Fumagalli D, Sonik R, De Vitis LA, et al. Evaluating nutrition in advanced ovarian cancer: which biomarker works best? Gynecol Oncol. 2024. PMID: 38943693. doi:10.1016/j.ygyno.2024.06.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。